July 15, 2022
The Centers for Medicare and Medicaid Services is rethinking a policy that limits millions of Americans’ access to one of the most effective resources for diagnosing and determining the course of treatment for Alzheimer’s disease.
July 13, 2022
Evidence continues to mount that exclusion lists – lists of prescription drugs that payers refuse to cover – have less to do with patients and more to do with profits.
July 7, 2022
A new treatment is expanding options for the 40 million people living with migraine disease.
July 5, 2022
Even as the federal investigation of pharmacy benefit managers begins, patients continue to get cheated by the companies’ practices.
June 30, 2022
More than two in five American adults are obese. Annually, 300,000 people die from the illness and hundreds of thousands more from related conditions.
June 28, 2022
The behind-the-scenes, yet powerful companies who control patients’ access to drugs may soon have to answer for their tactics.
June 24, 2022
In a victory for patient protections, a federal appellate court upheld a West Virginia law designed to put guardrails on unscrupulous “bad drug” advertising.
June 21, 2022
There are more than one hundred types of arthritis, but gout is among the most common and the most painful.…
June 17, 2022
Imagine being told you’ll have to self-inject a medication – without instructions – that has only been FDA approved for provider-administration. Chances are, you may not use it at all, even though it means inviting dangerous symptoms.
June 16, 2022
The Partnership to Advance Cardiovascular Health brought together patient advocates, health care providers and policy experts to discuss solutions to overcome the hurdles that keep cardiovascular patients from accessing the most appropriate care.
